Evercore

Evercore Inc., formerly known as Evercore Partners,^[2] is a global independent investment banking advisory firm founded in 1995 by Roger Altman, David Offensend, and Austin Beutner.^[3] The firm has advised on over $4.7 trillion of merger, acquisition, and restructuring transactions since its founding.^[4] Evercore is widely considered one of the most prestigious and elite investment banking advisory firms.^[5]

Evercore Inc.

Headquarters at Park Avenue Plaza
Formerly	Evercore Partners Inc.
Type	Public
Traded as	NYSE: EVR (Class A) S&P 400 component
Industry	Investment banking
Founded	1995; 28 years ago (1995)
Founder	Roger Altman
Headquarters	New York City, United States
Key people	Roger Altman (Founder and Senior Chairman) John S. Weinberg (Chairman of the Board of Directors and CEO) Ralph Schlosstein (Chairman Emeritus)
Products	Investment banking Investment management Equity research
Revenue	US$3.29 billion (2021)^[1]
Operating income	US$1.10 billion (2021)^[1]
Net income	US$740 million (2021)^[1]
Total assets	US$3.80 billion (2021)^[1]
Total equity	US$1.32 billion (2021)^[1]
Number of employees	1,950 (2022)^[1]
Website	www.evercore.com

Evercore's Investment Banking business advises its clients on mergers and acquisitions, divestitures, restructurings, financings, public offerings, private placements and other strategic transactions and also provides institutional investors with macro and fundamental equity research, sales and trading execution through Evercore ISI. Evercore's Investment Management business comprises wealth management, institutional asset management and private equity investing.

Evercore is headquartered in New York City and serves clients from 28 offices in 11 countries across North America, Europe, South America and Asia, with approximately 1,950 employees globally.^[6]

History

Founding and establishment

Source:^[7]

Evercore Partners was founded by Roger C. Altman in 1995, on the basis that clients would be best served by an investment banking firm free of the conflicts of interest of large financial institutions like Goldman Sachs and Merrill Lynch.

Roger Altman began his career in investment banking at Lehman Brothers, serving as general partner until 1977. After a role as assistant secretary of the U.S. Treasury until 1981, Altman returned to Lehman as co-head of global investment banking.

In 1987, Altman joined The Blackstone Group as its head of advisory business before returning to the U.S. Treasury to serve as deputy secretary in 1993.

In 1995, Altman founded Evercore Partners.

Today, Evercore operates as the world's leading independent investment bank, where Altman continues to serve as Senior Chairman in the business.^[1]

Recent activities

• In 2009 Evercore advised Wyeth in the largest deal of the year. In 2010 the firm advised Genzyme in the largest healthcare deal of the year.^[8]
• In August 2011, the firm completed its acquisition of Lexicon Partners, an independent UK-based investment banking advisory firm.^[9]
• In October 2011, Evercore and Kotak Mahindra Capital Company Limited ("Kotak Investment Banking") (a subsidiary of Kotak Mahindra Bank Limited), announced that the two firms had entered into an exclusive strategic alliance for cross-border M&A advisory services between India and the United States, the United Kingdom, and Mexico.^[9]
• In November 2011, the firm announced that it had agreed to purchase a 45% non-controlling interest in ABS Investment Management, an institutionally focused equity long/short hedge fund of funds manager.^[9]
• In 2012 Evercore advised Kraft in the largest Consumer/Retail deal of the year, as well as TNK-BP in the largest Energy deal of the year.^[10][11]
• In 2013 Evercore advised Dell in the largest technology deal of the year.^[12]
• In April 2014, former Evercore banker Perkins Hixon pleaded guilty to insider trading in the securities of Evercore, Westway Group Inc. and Titanium Metals Corporation^[13] from 2010 to 2013. He resigned from the company earlier in 2014.^[14]
• In August 2014, Evercore announced the acquisition of International Strategy & Investment ("ISI") Group for $440 million.^[15][16] The deal was closed the following October to create Evercore ISI Institutional Equities, offering Macro and Fundamental Research, Sales, and Trading execution. In 2014, the firm secured the second highest number of Institutional Investor #1 positions, after J.P. Morgan, and also ranked No. 5 in total II positions.^[17] The same year, Evercore advised AstraZeneca in its defense against Pfizer's hostile takeover.
• Other M&A assignments include advising DuPont on its $68 billion merger of equals with The Dow Chemical Company to create DowDuPont;^[18] Medivation on its sale to Pfizer Inc., and Abbott Laboratories on its $31 billion acquisition of St. Jude Medical in the two largest Healthcare transactions of 2016.^[19] In addition, the company advised Qualcomm on its pending acquisition of NXP Semiconductors NV in the largest Technology transaction of that year. Evercore also advised Centurylink on its pending acquisition of Level 3 Communications Inc. in the largest Telecom transaction of 2016, and Tesla, Inc. on its $2 billion acquisition of SolarCity.^[20]
• Also in 2016, John S. Weinberg joined Evercore from Goldman Sachs as Chairman of the Board and Executive Chairman.^[21]
• In 2017, Evercore advised Coach, Inc. on its $2 billion acquisition of Kate Spade New York;^[22] Whole Foods Market on its $14 billion sale to Amazon;^[23] CVS on its acquisition of Aetna in the largest Healthcare deal of the year; and Qualcomm on its successful defense against Broadcom in the largest contested Technology deal ever.^[24]
• In 2018 Evercore has advised the Independent Committee of the Board of Directors of T-Mobile U.S. on its $25.6 billion acquisition of Sprint Corporation,^[25] Takeda Pharmaceutical Company Limited on its $62.2 billion acquisition of Shire plc,^[26] and Comcast Corporation on its $39 billion acquisition of Sky plc.^[27]
• In 2019 Evercore advised National Amusements, Inc. on its $12 billion combination of CBS Corp. and Viacom Inc.,^[28] Anadarko Petroleum on its $55 billion sale to Occidental Petroleum,^[29] and Bristol-Myers Squibb on its $74 billion acquisition of Celgene Corporation in the largest M&A deal of the year.^[30]
• In 2020 Evercore advised AstraZeneca on its $39 billion acquisition of Alexion Pharmaceuticals in the largest healthcare M&A deal of the year.^[31]
• In 2023 Manfred Affenzeller invested a stake in Evercore ISI worth $148 million.^{[citation needed]}

See also

• Investment banking
• List of investment banks
• Boutique investment bank

References

1. "Form 10-K Annual Report for the Fiscal Year Ended December 31, 2021 Evercore Inc". SEC.gov. U.S. Securities and Exchange Commission. 24 February 2022.
2. "Evercore Partners Inc". The New York Times. ISSN 0362-4331. Retrieved 2017-09-25.
3. Evercore Makes a Bid for Court TV - NY Times
4. "Who We Are". Evercore. Retrieved 2022-02-12.
5. "Evercore has torched competitors" (PDF).
6. Boyd, Michael (2017-08-08). "Evercore: Underfollowed Firm Has Great Potential". Seeking Alpha. Retrieved 2017-09-25.
7. "Roger C. Altman". Evercore. Retrieved 2022-02-12.
8. "The Pharmaceuticals Banker That Helped Evercore Land a $4 Billion Mandate". The Wall Street Journal. 2009-07-31.
9. Evercore Partners 2011 Financial News
10. "Evercore Kraft Spin Off". Financial News. 2011-08-05.
11. "BP's Partner in TNK-BP Looks to Sell Stake". Financial Times. 2012-10-08. Archived from the original on 2022-12-11.
12. "Legions of Advisers for Dell EMC Deal". The New York Times. 2015-10-13.
13. Pital, Sisal S., "Ex-Evercore director guilty of insider trading", MarketWatch, April 3, 2014. Retrieved 2014-04-03.
14. Calder, Rich and Josh Kosman, "Perk Hixon, ex-Evercore banker, to plead guilty to insider trading", New York Post, April 2, 2014. Retrieved 2014-04-03.
15. "Evercore buys ISI brokerage for up to $440m". Financial Times. Archived from the original on 2022-12-11. Retrieved 2017-09-25.
16. Roberts, Lee (2014-08-03). "Evercore Partners to Acquire ISI Group". The Wall Street Journal. ISSN 0099-9660. Retrieved 2017-09-25.
17. Hurst, Georgina, "Evercore ISI Deal May Be Wave of the Future", Institutional Investor, October 9, 2014.
18. Gara, Antoine (December 11, 2015). "Dow and DuPont Merge In $130B Deal That Will Create DowDuPont, Before Breaking it Apart". Forbes. Retrieved March 29, 2018.
19. Picker, Leslie (April 28, 2016). "Abbott to Acquire St. Jude Medical for $25 Billion". The New York Times. Retrieved March 29, 2018.
20. Marino, Jon (August 1, 2016). "Tesla-SolarCity Deal Shuts Out Wall Street's Big Banks". CNBC. Retrieved March 29, 2018.
21. "Ex-Goldman Sachs Banker John Weinberg Joins Evercore As Chairman". Bloomberg. 2016-11-16.
22. Hoi-Nga Wong, Stephanie (May 8, 2017). "Coach Agrees to Buy Kate Spade For $2.4 Billion". Bloomberg L.P. Retrieved March 29, 2018.
23. "Here's Who Helped Amazon Clinch Blockbuster Whole Foods Deal". Fortune. June 16, 2017. Retrieved March 29, 2018.
24. "Broadcom Willing to go Hostile to Win $105 Billion Qualcomm Deal". Ad Age. 2017-11-06.
25. "T-Mobile to buy Sprint for $26.5 Billion". Bloomberg. 29 April 2018. Retrieved 2022-02-09.
26. "It's a Wrap! Takeda-Shire Merger Is a Done Deal, Making Takeda the Largest Mass. Biotech Employer". BioSpace. Retrieved 2022-02-09.
27. Browne, Spriha Srivastava,Alex Sherman,Ryan (2018-09-22). "Comcast outbids Fox in a $39 billion takeover of Sky". CNBC. Retrieved 2022-02-09.{{cite web}}: CS1 maint: multiple names: authors list (link)
28. "Viacom and CBS reunite in $12 billion deal, but challenges abound". Los Angeles Times. 2019-12-04. Retrieved 2022-02-09.
29. "Occidental Completes Acquisition of Anadarko". www.businesswire.com (Press release). 2019-08-08. Retrieved 2022-02-09.
30. "BMS Completes $74 Billion Celgene Takeover". BioSpace. Retrieved 2022-02-09.
31. "AstraZeneca closes mega $39B Alexion buyout despite antitrust fears, making a splash in rare diseases". FiercePharma. Retrieved 2022-02-09.

External links

• Official website
• Business data for Evercore Inc.:
  • Google
  • SEC filings
  • Yahoo!